European Society of Gastrointestinal Endoscopy (ESGE) Guideline: Prophylaxis of post-ERCP pancreatitis

被引：226

作者：

Dumonceau, J. -M. ^{[1
]}

Andriulli, A. ^{[2
]}

Deviere, J. ^{[3
,4
]}

Mariani, A. ^{[5
]}

Rigaux, J. ^{[3
,4
]}

Baron, T. H. ^{[6
]}

Testoni, P. A. ^{[5
]}

机构：

[1] Univ Hosp Geneva, Div Gastroenterol & Hepatol, Serv Gastroenterol & Hepatol, CH-1205 Geneva, Switzerland

[2] Casa Sollievo Sofferemza Hosp, IRCCS, Div Gastroenterol, San Giovanni Rotondo, Italy

[3] Erasme Univ Hosp, Dept Gastroenterol, B-1070 Brussels, Belgium

[4] Erasme Univ Hosp, Dept Hepatopancreat, B-1070 Brussels, Belgium

[5] Univ Vita Salute San Raffaele, IRCCS San Raffaele Hosp, Div Gastroenterol & Gastrointestinal Endoscopy, Milan, Italy

[6] Mayo Med Ctr, Dept Med, Div Gastroenterol & Hepatol, Rochester, MN USA

来源：

ENDOSCOPY | 2010年 / 42卷 / 06期

关键词：

RETROGRADE CHOLANGIOPANCREATOGRAPHY PANCREATITIS; RANDOMIZED CONTROLLED-TRIAL; BILE-DUCT STONES; SELECTIVE BILIARY CANNULATION; PLACEBO-CONTROLLED TRIAL; MAJOR DUODENAL PAPILLA; HIGH-RISK PATIENTS; BALLOON DILATION; PROSPECTIVE MULTICENTER; THERAPEUTIC ERCP;

D O I：

10.1055/s-0029-1244208

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Pancreatitis is the most common complication of endoscopic retrograde cholangiopancreatography (ERCP). Risk factors for post-ERCP pancreatitis (PEP) are both patient-related and procedure-related. Identification of patients at high risk for PEP is important in order to target prophylactic measures. Prevention of PEP includes administration of nonsteroidal inflammatory drugs (NSAIDs), use of specific cannulation techniques, and placement of temporary pancreatic stents. The aim of this guideline commissioned by the European Society of Gastrointestinal Endoscopy (ESGE) is to provide practical, graded, recommendations for the prevention of PEP.

引用

页码：503 / 515

页数：13